Sign inGet started

Kirsch Arthur S

Insider CIK 1290976 · POZN Director · LQDA Director · KDMN Director · AVIR Director · ARLZ Director · LQDA Director · EVMN Director · IMMU Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
EVMN Evommune, Inc. P Buy2026-07-072026-07-0810,000$13.30 $133.0K10,000SEC↗
AVIR Atea Pharmaceuticals, Inc. A Award deriv2026-06-182026-06-2326,700— $026,700SEC↗
AVIR Atea Pharmaceuticals, Inc. A Award deriv2026-06-182026-06-2337,700— $037,700SEC↗
LQDA Liquidia Corp A Award2026-06-162026-06-185,882— $046,637SEC↗
LQDA Liquidia Corp S Sale2026-06-032026-06-0310,000$54.80 $548.0K0SEC↗
EVMN Evommune, Inc. A Award deriv2026-06-022026-06-0315,673— $015,673SEC↗
LQDA Liquidia Corp S Sale2026-06-022026-06-035,000$56.00 $280.0K10,000SEC↗
LQDA Liquidia Corp S Sale2026-06-012026-06-0315,000$60.22 $903.3K15,000SEC↗
EVMN Evommune, Inc. A Award deriv2025-11-052025-11-0737,960— $037,960SEC↗
LQDA Liquidia Corp A Award2025-06-172025-06-2018,396— $040,755SEC↗
AVIR Atea Pharmaceuticals, Inc. A Award deriv2025-02-202025-02-24164,800— $0164,800SEC↗
LQDA Liquidia Corp A Award2024-06-202024-06-2420,359— $022,359SEC↗
LQDA Liquidia Corp A Award deriv2023-06-192023-06-2120,000— $020,000SEC↗
LQDA Liquidia Corp A Award deriv2022-06-172022-06-2220,000— $020,000SEC↗
LQDA Liquidia Corp P Buy2021-11-102021-11-1230,000$4.24 $127.2K32,000SEC↗
KDMN Kadmon Holdings, Inc. D To issuer deriv2021-11-092021-11-0996,975$5.92 $574.1K0SEC↗
KDMN Kadmon Holdings, Inc. D To issuer deriv2021-11-092021-11-0985,034$5.06 $430.3K0SEC↗
KDMN Kadmon Holdings, Inc. D To issuer deriv2021-11-092021-11-09100,000$7.21 $721.0K0SEC↗
KDMN Kadmon Holdings, Inc. D To issuer deriv2021-11-092021-11-0964,103$7.21 $462.2K0SEC↗
KDMN Kadmon Holdings, Inc. D To issuer2021-11-092021-11-0930,000$9.50 $285.0K0SEC↗
LQDA Liquidia Corp A Award deriv2021-08-202021-09-0120,000— $020,000SEC↗
KDMN Kadmon Holdings, Inc. A Award2021-05-142021-05-1710,000$3.70 $37.0K30,000SEC↗
KDMN Kadmon Holdings, Inc. A Award2021-05-132021-05-1720,000$3.58 $71.6K20,000SEC↗
KDMN Kadmon Holdings, Inc. A Award deriv2021-05-122021-05-1396,975— $096,975SEC↗
LQDA Liquidia Corp A Award deriv2021-03-242021-03-2641,390— $041,390SEC↗
LQDA Liquidia Technologies Inc A Award deriv2020-06-222020-06-2320,000— $020,000SEC↗
KDMN Kadmon Holdings, Inc. A Award deriv2020-05-132020-05-1485,034— $085,034SEC↗
LQDA Liquidia Technologies Inc A Award deriv2019-08-292019-09-037,500— $07,500SEC↗
KDMN Kadmon Holdings, Inc. A Award deriv2019-05-152019-05-1664,103$2.29 $146.8K64,103SEC↗
KDMN Kadmon Holdings, Inc. A Award deriv2019-05-152019-05-16100,000$2.29 $229.0K164,103SEC↗
LQDA Liquidia Technologies Inc P Buy2018-11-142018-11-15895$18.50 $16.6K2,000SEC↗
LQDA Liquidia Technologies Inc P Buy2018-11-132018-11-15105$18.00 $1.9K1,105SEC↗
LQDA Liquidia Technologies Inc P Buy2018-11-082018-11-131,000$18.25 $18.3K1,000SEC↗
LQDA Liquidia Technologies Inc A Award deriv2018-07-252018-07-2710,050— $010,050SEC↗
ARLZ Aralez Pharmaceuticals Inc P Buy2017-12-082017-12-1250,000$1.47 $73.5K271,609SEC↗
ARLZ Aralez Pharmaceuticals Inc P Buy2017-06-152017-06-1915,000$1.15 $17.3K221,609SEC↗
ARLZ Aralez Pharmaceuticals Inc P Buy2017-06-142017-06-1650,000$1.17 $58.5K206,609SEC↗
ARLZ Aralez Pharmaceuticals Inc A Award deriv2017-05-112017-05-1215,000— $015,000SEC↗
ARLZ Aralez Pharmaceuticals Inc A Award2017-05-112017-05-127,500— $0156,609SEC↗
ARLZ Aralez Pharmaceuticals Inc P Buy2017-03-152017-03-1745,000$2.27 $102.2K149,109SEC↗
ARLZ Aralez Pharmaceuticals Inc A Award deriv2016-06-162016-06-2015,000— $015,000SEC↗
ARLZ Aralez Pharmaceuticals Inc A Award2016-06-162016-06-207,500— $0104,109SEC↗
ARLZ Aralez Pharmaceuticals Inc P Buy2016-05-122016-05-1622,500$3.49 $78.5K96,609SEC↗
ARLZ Aralez Pharmaceuticals Inc P Buy2016-05-122016-05-165,000$3.49 $17.4K5,000SEC↗
ARLZ Aralez Pharmaceuticals Inc M Exercise deriv2016-02-052016-02-086,107— $00SEC↗
ARLZ Aralez Pharmaceuticals Inc J Other deriv2016-02-052016-02-096,107— $06,107SEC↗
ARLZ Aralez Pharmaceuticals Inc J Other deriv2016-02-052016-02-096,107— $06,107SEC↗
ARLZ Aralez Pharmaceuticals Inc J Other deriv2016-02-052016-02-096,107— $06,107SEC↗
ARLZ Aralez Pharmaceuticals Inc M Exercise2016-02-052016-02-086,107$5.97 $36.5K64,719SEC↗
ARLZ Aralez Pharmaceuticals Inc J Other2016-02-052016-02-0964,719— $064,719SEC↗
POZN POZEN INC /NC M Exercise deriv2016-01-202016-01-226,107— $00SEC↗
POZN POZEN INC /NC M Exercise2016-01-202016-01-226,107$5.40 $33.0K58,612SEC↗
IMMU IMMUNOMEDICS INC A Award deriv2015-12-022015-12-0414,469— $014,469SEC↗
IMMU IMMUNOMEDICS INC A Award deriv2015-12-022015-12-0428,821— $028,821SEC↗
POZN POZEN INC /NC M Exercise deriv2015-10-202015-10-216,107— $00SEC↗
POZN POZEN INC /NC M Exercise deriv2015-10-202015-10-216,107— $00SEC↗
POZN POZEN INC /NC M Exercise2015-10-202015-10-216,107$3.84 $23.5K46,398SEC↗
POZN POZEN INC /NC M Exercise2015-10-202015-10-216,107$4.44 $27.1K52,505SEC↗
IMMU IMMUNOMEDICS INC A Award deriv2015-08-182015-08-2022,500— $022,500SEC↗
POZN POZEN INC /NC A Award2015-06-102015-06-129,390— $049,681SEC↗
POZN POZEN INC /NC M Exercise deriv2014-06-112014-06-129,430— $00SEC↗
POZN POZEN INC /NC M Exercise2014-06-112014-06-129,430$5.78 $54.5K49,721SEC↗
POZN POZEN INC /NC S Sale2014-06-112014-06-129,430$9.30 $87.7K40,291SEC↗
POZN POZEN INC /NC M Exercise deriv2014-06-052014-06-062,500— $09,430SEC↗
POZN POZEN INC /NC S Sale2014-06-052014-06-062,500$8.67 $21.7K40,291SEC↗
POZN POZEN INC /NC M Exercise2014-06-052014-06-062,500$5.78 $14.4K42,791SEC↗
POZN POZEN INC /NC A Award2014-06-042014-06-069,291— $040,291SEC↗
POZN POZEN INC /NC M Exercise deriv2014-06-022014-06-032,500— $011,930SEC↗
POZN POZEN INC /NC S Sale2014-06-022014-06-032,500$8.73 $21.8K26,000SEC↗
POZN POZEN INC /NC M Exercise2014-06-022014-06-032,500$5.78 $14.4K28,500SEC↗
POZN POZEN INC /NC M Exercise deriv2014-05-272014-05-272,900— $014,430SEC↗
POZN POZEN INC /NC M Exercise2014-05-272014-05-272,900$5.78 $16.8K28,900SEC↗
POZN POZEN INC /NC S Sale2014-05-272014-05-272,900$8.44 $24.5K26,000SEC↗
POZN POZEN INC /NC M Exercise deriv2014-05-222014-05-277,100— $017,330SEC↗
POZN POZEN INC /NC S Sale2014-05-222014-05-277,100$8.36 $59.4K26,000SEC↗
POZN POZEN INC /NC M Exercise2014-05-222014-05-277,100$5.78 $41.0K33,100SEC↗
POZN POZEN INC /NC A Award deriv2013-06-062013-06-105,000— $05,000SEC↗
POZN POZEN INC /NC A Award2013-06-062013-06-105,000— $031,000SEC↗
POZN POZEN INC /NC A Award deriv2012-06-072012-06-115,000— $05,000SEC↗
POZN POZEN INC /NC A Award2012-06-072012-06-115,000— $026,000SEC↗